Conjugated‐Polymer‐Based Photodynamic Therapy.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200165
- By:
- Publication type:
- Article
Works matching IS 23663987 AND DT 2022 AND VI 5 AND IP 12
Results: 15
1
2
Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy (Adv. Therap. 12/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202270030
- By:
- Publication type:
- Article
3
Masthead (Adv. Therap. 12/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202270029
- Publication type:
- Article
4
Umbilical Cord Mesenchymal Stem Cells Promoting Spinal Cord Injury Repair Visually Monitored by AIE‐Tat Nanoparticles (Adv. Therap. 12/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202270028
- By:
- Publication type:
- Article
5
A Tumor‐Organoid‐Based Precision Medicine Platform for the Prediction of Drug Sensitivity of Colorectal Cancer (Adv. Therap. 12/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202270027
- By:
- Publication type:
- Article
6
Liposome‐Mediated Biomimetic Delivery of PLK3 Inhibitor with NIR II‐Triggered Release Prevents Renal Ischemia‐Reperfusion Injury (Adv. Therap. 12/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202270031
- By:
- Publication type:
- Article
7
Efficacy and Safety of Inosine Pranobex in COVID‐19 Patients: A Multicenter Phase 3 Randomized Double‐Blind, Placebo‐Controlled Trial.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200159
- By:
- Publication type:
- Article
8
Thrombin‐Loaded Magnetic Microbubbles for the Treatment of Pseudoaneurysms.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200115
- By:
- Publication type:
- Article
9
Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200109
- By:
- Publication type:
- Article
10
Oxygen‐Generated Hierarchical‐Structured AuNRs@MnO<sub>2</sub>@SiO<sub>2</sub> Nanocarrier for Enhanced NIR‐ and H<sub>2</sub>O<sub>2</sub>‐Responsive Mild‐Hyperthermia Photodynamic/Photothermal Combined Tumor Therapy.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200108
- By:
- Publication type:
- Article
11
A Biomimetic Nanomedicine Targets Orthotopic Glioblastoma by Combinatorial Co‐Delivery of Temozolomide and a Methylguanine‐DNA Methyltransferase Inhibitor.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200095
- By:
- Publication type:
- Article
12
Mitochondrial‐Targeting Vitamin B<sub>3</sub> Ameliorates the Phenotypes of Parkinson's Disease In Vitro and In Vivo by Restoring Mitochondrial Function.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200094
- By:
- Publication type:
- Article
13
A Tumor‐Organoid‐Based Precision Medicine Platform for the Prediction of Drug Sensitivity of Colorectal Cancer.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200093
- By:
- Publication type:
- Article
14
Liposome‐Mediated Biomimetic Delivery of PLK3 Inhibitor with NIR II‐Triggered Release Prevents Renal Ischemia‐Reperfusion Injury.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200087
- By:
- Publication type:
- Article
15
Umbilical Cord Mesenchymal Stem Cells Promoting Spinal Cord Injury Repair Visually Monitored by AIE‐Tat Nanoparticles.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 12, p. 1, doi. 10.1002/adtp.202200076
- By:
- Publication type:
- Article